Skip to Content

nav = $navtool.getNav(1)

TL1 trainees attend ACTS Translational Science 2024

May 01, 2024
Tracey Barnett/ MD Anderson UTHealth Houston Graduate School

TL1 trainees attend ACTS Translational Science 2024

Six trainees with the Predoctoral & Postdoctoral Training in Clinical & Translational Sciences at UTHealth Houston and MD Anderson Cancer Center (TL1) participated in the Association of Clinical and Translational Science (ACTS) Conference in Las Vegas from April 3-5.

Those trainees were:

  • Meagan Conner – Cancer Biology Program; Advisor: Raghu Kalluri, MD, PhD
  • Stephen Farmer – Immunology Program; Advisor: Sheng Zhang, PhD
  • Grace Murley – Quantitative Sciences Program; Advisors: C. David Fuller, MD, PhD, and Pratip Bhattacharya, PhD
  • Nicolas Moreno – Molecular and Translational Biology Program; Advisor: Changqing (Cynthia) Ju, PhD
  • Lea Stitzlein – Therapeutics and Pharmacology Program; Advisor: Joya Chandra, PhD
  • Lacin Yapindi - Thoracic/Head and Neck Medical Oncology (MD Anderson); Advisor: Faye Johnson, MD, PhD

This event gave the trainees the opportunity to present their research during a poster presentation and learn more about translational science. ACTS currently represents nearly 5,000 members who are involved in academic institutions, industry, philanthropic agencies, and government; and is committed to providing its members a platform for advancing the discipline of clinical and translational science with which it relates to improving human health.

Highlights from the conference include Nicolas Moreno being recognized as one of the "top 25% TL1-T32” poster awardees, and Meagan Conner being selected as one of the top 50 abstracts and presenting her work at the event. 

" We are super proud of our trainees,” said TL1 Program Manager Jewel Elliott. “We look forward to the conference next year.”

See more photos from the conference here.

To learn more about the TL1 Program, please visit


site var = gsbs